← FDA Drug Approvals (Drugs@FDA)

NEORAL

NDA · New Drug Application · Sponsor: NOVARTIS · Approved 1995-07-14

Drug application

FDA Application #

NDA050716

Application type

New Drug Application

Brand name

NEORAL

Generic name

CYCLOSPORINE

Active ingredients

CYCLOSPORINE

Dosage form

SOLUTION

Route

ORAL

Marketing status

Prescription

Sponsor

NOVARTIS

Manufacturer

Novartis Pharmaceuticals Corporation

First approval

1995-07-14

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown